Short description
Corus Pharma Inc., a Seatle-based biotech and specialty drug company focused on respiratory and infectious diseases.
Description
Corus Pharma is a biotech and specialty drug company that focuses on respiratory and infectious diseases. In other words, it is a development stage biopharmaceutical company that focuses on the development and commercialization of novel applications and formulations of known therapeutics to treat severe respiratory diseases. The products of the company are Corus 1020 and 1030. Corus 1020 is designed to treat respiratory infections in cystic fibrosis patients, using an inhalable form of an antibiotic called aztreonam. Corus 1030 is inhaled lidocaine for the treatment of patients suffering from the severe persistent forms of asthma.
Corus Pharma is a U.S.-based company that was founded in 2001 and the company was acquired by Gilead Sciences on October 22, 2006.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Seattle, Washington, United States, North America
Founded on
January 1, 2001
Closed on
August 11, 2006
Exited on
October 22, 2006
Non-profit?
No
Acquired?
No
Employees count
501-1000
Investors
Cannot Access, No Way, Noaccessforu, Noway Youcantaccess, Uh Ohhhh, Cannot Access, Noaccessforu, Blurry Noaccess, No Way, Noway Youcantaccess, Nopepepe, Noaccessforu, Noaccess, Uh Ohhhh, Noaccess, Nopepepe, Noaccess, Blurry Noaccess, Blurry Noaccess, Noaccess
Sign in for full access